Cart
sales@molnova.com
GEBR-7b
CAS No. 67387-76-2
GEBR-7b( 3-(Cyclopentyloxy)-4-methoxybenzaldehyde )
Catalog No. M27181 CAS No. 67387-76-2
GEBR-7b is a phosphodiesterase-4 (PDE4) inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 33 | In Stock |
|
| 5MG | 28 | In Stock |
|
| 10MG | 43 | In Stock |
|
| 25MG | 73 | In Stock |
|
| 50MG | 107 | In Stock |
|
| 100MG | 160 | In Stock |
|
| 200MG | 241 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGEBR-7b
-
NoteResearch use only, not for human use.
-
Brief DescriptionGEBR-7b is a phosphodiesterase-4 (PDE4) inhibitor.
-
DescriptionGEBR-7b is a phosphodiesterase-4 (PDE4) inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms3-(Cyclopentyloxy)-4-methoxybenzaldehyde
-
PathwayAngiogenesis
-
TargetPDE
-
Recptorhuman HEPG2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number67387-76-2
-
Formula Weight220.268
-
Molecular FormulaC13H16O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOc1ccc(C=O)cc1OC1CCCC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Joerg Kley, et al. Sulfonamides as inhibitors of the uptake of extracellular citrate. Patent WO2018104220A1
molnova catalog
related products
-
BAY 2666605
BAY 2666605 is an orally active inhibitor of PDE3A and PDE3B with IC50s of 87 nM and 50 nM, respectively. BAY 2666605 has anticancer effects.
-
PQ-10
PQ-10 is a PDE-10 inhibitor. PQ-10 induces brain glucose metabolism patterns, which may be a potential translational biomarker.
-
Ensifentrine
Ensifentrine is a PDE3/4 inhibitor, although its affinity for PDE3(IC50: 0.4 nM) is 3,440 times higher than that for PDE4(IC50: 1479 nM), that is under clinical development for the treatment of asthma and COPD and, potentially, cystic fibrosis.
